Directed mutagenesis in mammalian cells
Introduction
Recent developments have shown that RNA-DNA chimeric oligonucleotide, small fragments of single-and double-stranded DNA (SFHR/SDF) as well as DNA vecors, can effectively perform targeted alteration of genomic sequences. [1] [2] [3] The use of both circular and linear RNA-DNA chimeric oligonucleotide (RDO) has been shown to induce gene conversion in cell cultures and in vivo, 2, 4 but their mechanism of action is still largely unknown and their efficiency seems variable and unpredictable. Homologous recombination may be an ideal way for gene conversion, since it is usually an error-free process. Several methods (SFHR/SDF, vector DNA) have been developed to facilitate gene replacement and gene knockout by sitespecific homologous recombination, 5, 6 but the efficiency is usually low. Therefore the development of tools for targeted modification of genomic DNA remains a topic of great interest, and will have important implications for gene therapy and development of transgenic animals.
Oligonucleotide-directed triple helix formation provides a rational basis for sequence-specific DNA targeting and has been widely used to interfere with gene expression ('antigene' strategies). 7 It has been unambigu- ously demonstrated that transcription can be efficiently inhibited by forming a stable triple helix that competes with the binding of transcriptional factors in the promoter region on a transient expression system in cells. It has also been shown that, at least, some of the target DNA sequences in native chromatin context are accessible to triple helix-forming oligonucleotide (TFO) covalently linked to a DNA-crosslinking agent (psoralen). Subsequently, it has been convincingly shown that transcription elongation can be inhibited by TFO in cells on both extrachromosomally and chromosomally integrated targets through a triple helix-mediated mechanism (reviewed in Ref. 8) .
TFOs have been used to target mutations or to promote homologous recombination at selected sites in cells and in vivo via the induction of a DNA repair-dependent process. It has been shown that TFOs either alone or tethered to a DNA-damaging agent (psoralen) can induce an unpredictable spectrum of point mutation and deletion/insertion around the triplex sites located both in an extrachromosomal vector and in chromosomal DNA. They can also stimulate homologous recombination and gene conversion within and between extrachromosomal vectors at selected sites in mammalian cells and in vivo. Triple helix-induced mutagenesis seems to be associated with nucleotide excision repair or transcription-coupled repair pathways, however the understanding of the precise mechanism requires further investigation (reviewed in Ref. 9 ).
TFOs have been chosen to guide homologous donor DNA (DD) to its intended target site on an extrachromosomal gene and to position it for efficient information transfer via homologous recombination and/or gene conversion. 10 In this approach, TFO is covalently tethered to DD through a linker. The effectiveness of the TFO-DD conjugate could be explained by: (1) an increase in the local concentration of DD; and (2) a stimulation of DNA repair by triple helix formation that could provoke recruitment of proteins involved in homologous pairing, strand exchange and/or recombination. 11 We have recently described a new approach named 'GOREC' (for guided homologous recombination) which shares similar gene targeting strategy by oligonucleotidedirected triple helix formation, but has notable difference in the concept. 12 It is made of a homing device (TFO) and a donor DNA (DD) for effecting distinct functions. They are joined together by non-covalent interaction through an adapter oligonucleotide, which is covalently linked to TFO (Figure 1b ). This modular concept can guide not only an oligonucleotide (ODN, RDO), but also a small DNA fragment (either single-or double-stranded) to the target site for homologous replacement. Therefore, the target site is not restricted to the vicinity of the triple helix site as is the case for the TFO-DD conjugate and can be hundreds of base pairs away from the triplex site. Our previous in vitro study has shown that the presence of TFO accelerates the D-loop formation between DD and the target DNA in the presence of RecA protein, and both triplex and D-loop are formed in the joint molecule (an obligatory intermediate and a limiting step in homologous recombination process). 12 These data were consistent with the rationale of the GOREC approach in order to stimulate the early stages of homologous recombination by improving two limiting steps: (1) search of sequence homology; (2) stability of recombinasemediated transient complex (joint molecule). The knowledge of the kinetic behavior (lifetime) of triplex and the duplex formed by adapter and donor DNA allows finetuning of the GOREC system.
Here we report preliminary data on a proof-of-principle assay, where TFOs are used to guide a PCR amplified 759-nt single-stranded or 759-bp double-stranded donor DNA fragment to restore the expression of an eGFP gene on a transfected plasmid in cells. The use of the GOREC method for site-directed correction of genetic defects and for gene alteration will be discussed.
Results

Description of episomal assay
The plasmid pEGFP-C1 carrying an eGFP gene is used in this work. The mutant pEGFPstop plasmid was constructed to introduce a stop mutation (TAC→TGA) at codon 66 of eGFP by site-directed mutagenesis. A triple helix site was further placed at the 3'-end of the eGFP gene in both pEGFP-C1 and pEGFPstop plasmids. Figure  1 shows the plasmid constructs and the GOREC systems used in this study. The single-stranded donor DNA (ssDD) was prepared by PCR amplification on the wild eGFP gene with a pair of primers in which one of them (1360) was biotinylated, and followed by capture of the ssDD on streptavidin-coated magnetic beads and then denaturation. The double-stranded donor DNA (dsDD)
Figure 1 (a) Constructs of plasmids used in this work (see Materials and methods). (b) Construct of pEGFPstopTPX plasmid. A stop codon was introduced at the position 810 in the eGFP gene. A site for triple helix formation (TPX) was cloned at the 3' end of eGFP. GOREC molecule is made of a triple helix-forming oligonucleotide (TFO, heavy grey box) tethered to an adapter oligonucleotide (bright grey line) through a linker. Two arrows indicate the primers used for the preparation of ssDD and dsDD by PCR amplification (see Materials and methods). (c) The oligopyrimidine/oligopurine sequence used for triple helix formation is boxed. The sequence of two GOREC molecules are given. The TFOs are 5' tethered by an acridine (W) and 3' linked to a 12-nt oligonucleotide (adapter, italic letters) through a tri-or hexaethyleneglycol linker (S or L, respectively). Modified nucleotides are used in TFOs: u, C5-propynyluracil; O, C5-methylcytosine; g, 7-deazaguanine; t and o, thymine and C5-methylcytosine in 2'-O,4'-C bridge locked nucleic acids, respectively.
was also prepared by PCR amplification on the wild eGFP gene with the primer 601 and the adapter of the guide part of GOREC molecule (made of TFO-linkeradapter) which replaced the primer 1360. Therefore the dsDD was covalently linked to the guide (TFO). The plasmids and the GOREC molecules (guide + DD) was cotransfected into Chinese hamster ovarian cells (CHO-K1) with polyethyleneimine (PEI). The correction of the stop codon in the mutant eGFP was restored as demonstrated by its expression, and subsequently green fluorescence in cells that provides an easy (but not quantitative) assay system for a proof-of-principle test of the GOREC method in cultured cells.
Triple helix-forming oligonucleotides
Sequence-specific dsDNA recognition by TFO via stable triple helix formation under physiological conditions at neutral pH and 37°C is a prerequisite in the GOREC approach. As depicted in Figure 1c , an 18-bp oligopyrimidine/oligopurine sequence that had been chosen and cloned in the pEGFPstopTPX and pEGFP-TPX plasmids. Two TFOs were designed to form stable triple helix at this site. They were covalently attached to the 12-nt oligonucleotide (adapter) through a tri-or hexaethyleneglycol spacer (TFO1-S and TFO2-L, respectively, Figure 1c) .
Thermal stability and binding affinity DNA melting experiments by UV spectrophotometer were first carried out to assess the thermal stability of triple helix formation by TFOs as previously described. 12 Briefly, a hairpin duplex containing the 18-bp oligopyrimidine/oligopurine target sequence (5'-CGTCT AGAAAAGAAAAGGGGGGATACGC-T 4 -GCGTATCC CCCCTTTTCTTTTCTAGACG-3', designated as 18YR) was used. Biphasic transitions were observed on the melting curves of the samples containing 1 M duplex 18YR and 1.5 M TFO in 20 mM cacodylate buffer (pH 7.2) containing 50 mM NaCl and 5 mM MgCl 2 . The transition occurring at high temperature (70°C) was identical to that observed for the duplex alone, therefore it was attributed to duplex ↔ single-strand transition. The transition at lower temperature was assigned to triplex ↔ duplex + TFO transition, since the TFOs alone did not exhibit any melting profile. The melting temperature (Tm 3→2 ) of the triplex formed by TFO1-S or TFO2-L with 18YR was about 53°C and 60°C respectively, as measured by the first derivative of their melting curves.
Binding of TFO1-S and TFO2-L to the target dsDNA was evaluated by native polyacrylamide gel retardation assay in solution, as previously described. 12 It was observed that the binding constant (K D ) at 37°C of TFO1-S and TFO2-L was about 0.3 M and 0.1 M, respectively. Previous studies have shown that the attachment of a 40-nt ssDD caused a two-fold decrease of binding affinity when a short spacer (triethyleneglycol) was used, whereas the loss was less pronounced when a longer spacer (hexaethylenglycol) was used. 12 Gene correction with single-stranded donor DNA In this assay, the amount of ssDD was kept constant (0.6 g). ssDD was titrated by TFO2-L at different stoichiometry (2 to 0.1). The assays were carried out by co-transfecting 0.04 g pEGFPstopTPX or pEGFP-TPX (as control) with either ssDD alone, or associated with the guide (TFO2-L + ssDD). After 48 h, the number of fluorescent cells transfected by pEGFPstopTPX plasmid with various DNA fragments was counted and compared with that of the cells transfected by the control plasmid pEGFP-TPX under the same condition. The ratio of fluorescent cells was used as an evaluation of extrachromosomal gene correction efficiency. It was observed that upon 1:1 ratio (TFO2-L + ssDD), about two-fold enhancement of gene correction was obtained (Figure 2 ). Ten-fold excess of TFO2-L did not greatly further increase gene correction.
Gene correction with double-stranded donor DNA
In this assay, the adapter in TFO1-S was used as one of the primers to produce a wild-type eGFP fragment. Such a 759-bp double-stranded donor (dsDD) was thus covalently linked to the guide. The assays were carried out by co-transfecting 0.04 g pEGFPstopTPX or pEGFP-TPX (as Gene Therapy control) with either dsDD alone, or associated with the guide (TFO1-S-dsDD) in the range of 0.2-1.2 g. They were performed in a similar way as for the ssDD assay. It was observed that the guided dsDD (TFO1-S-dsDD) was more efficient in gene correction than the unguided dsDD (Figure 3a) . The enhancement obtained by 1.2 g
Figure 3 Gene correction assay by double-stranded donor DNA alone (open box) or TFO1-S-ssDD (hatched box) (see text for details). (a) The correction rate was calculated by normalizing the data obtained with pEGFPstopTPX plasmid by those with the pEGFP-TPX control plasmid. (b) The ratio of the correction rates obtained for the plasmids pEGFPstopTPX and pEGFPstop.
TFO1-S-dsDD was about 2.6 as compared with 1.2 g dsDD alone.
A similar assay was carried out in which the control plasmid pEGFP-TPX was replaced by the plasmid pEGFPstop, which has a stop codon, but lacks the triple helix site. The ratio of the number of fluorescent cells transfected by pEGFPstopTPX and by pEGFPstop with dsDD or TFO1-S-dsDD would indicate the specificity of gene targeting by triple helix formation. As expected, the gain in gene correction by GOREC approach was shown by the observation that the lack of enhancement of gene correction in the cells treated by dsDD alone for all amount of transfected DNA, whereas the ratio was increased to about 1.5 and 2 for 0.2 g and 0.6-1.2 g transfected TFO1-S-dsDD, respectively (Figure 3b ).
Discussion
Altogether, the results presented have indicated that gene targeting by oligonucleotide-directed triple helix formation can effectively improve gene correction by homologous replacement, thus validating the GOREC method in cultured cells. This work has shown that the efficiency of gene repair by homologous recombination, between a 759-nt or a 759-bp donor DNA fragment prepared by PCR amplification and the target mutant DNA, can be significantly increased even when the triple helix site is about 550 base pairs away from the mutation site using the GOREC method. Therefore the GOREC method could be applied to a large number of genes of interest, because it is generally possible to find a suitable triple helix site within several hundred base pairs. It actually acts as a useful extension of the SFHR/SDF method and is also suitable for oligonucleotide (both ODN and RDO) approaches.
Much work is currently under way to apply the GOREC method to the integrated or endogenous genes (ie eGFP, HPRT, tyrosinase, CFTR, etc) in order to assess quantitatively the efficiency of gene correction in the native chromatin context. It also remains to be determined whether the non-covalent attachment between the guide element and the double-stranded donor DNA is of importance in vivo. There are at least two ways to attach non-covalently the dsDD to the TFO: (1) by strand invasion of the adapter into the dsDD prepared by normal PCR amplification, if the adapter were made of peptide nucleic acids; (2) by preparing a 5'-protruding dsDD at the proximal end if one or several ribonucleotide(s) were incorporated into the proximal primer and subsequently cleaved by alkali or enzymatic treatment.
Materials and methods
Oligonucleotides
Purified oligonucleotides were purchased from Eurogentec (Sering, Belgium), except TFO2-L which was bought from Proligo LLC (Boulder, CO, USA). Their concentrations were determined spectrophotometrically as previously described. 12 
Construction of plasmids
The mutant pEGFPstop plasmid was constructed to introduce a stop mutation (TAC→TGA) at codon 66 of eGFP gene from Clontech (Palo Alto, CA, USA) by site-directed mutagenesis. Two separate fragments were PCR amplified from the pEGFP-C1 plasmid. Mutation was contained in the downstream primer of one fragment (from 541 to 822) and in the upstream primer of the other fragment (from 802 to 1390). After purification, the fragments were mixed together and were used as templates to generate the mutant insert extending from position 541 to 1390. After digestion with BsrgI and Eco47III, the mutant fragment was ligated into pEGFP-C1 also digested by BsrgI and Eco47III. Colonies generated from transformation into DH5␣ were screened by digestion with DdeI, because the stop mutation introduced a new DdeI restriction site. A positive clone named pEGFPstop was sequenced to confirm mutation and subsequently used for pEGFPstopTPX construction and targeting experiments.
The pEGFP-TPX and pEGFPstopTPX plasmids contained the sequence of triple helix site (TPX) in the multiple cloning site of pEGFP-C1 vector and were constructed with synthetic oligonucleotides. Oligonucleotides 5'-ccgggtctagaaaagaaaaggggggatacgcgt ggccagc-3' and 5'-ccggcgtggccacgcgtatccccccttttcttttcta gac-3' were hybridized and ligated into pEGFP-C1 and pEGFPstop vectors digested with AvaI endonucleases (cutting positions 1344 and 1387). Ligation products were screened by XbaI digestion after DH5␣ transformation. Positive clones with TPX sequence had a new XbaI recognition site and were sequenced to confirm the presence of the TPX sequence.
Single-stranded and double-stranded donor DNA fragments Double-stranded donor DNA (dsDD) were produced by PCR amplification with primers 5'-ccggtcgccaccatggtgagc-3' and 5'-cgcgtggccagctcgagatc-3' (primers 601 and 1360 in Figure 2b ) and pEGFP-TPX as template. A 759-bp double strand amplicon was obtained and purified by gel (QIAEX II system; Qiagen, Hilden, Germany). An upstream biotinylated primer was used to prepare the single-stranded donor DNA (ssDD) by PCR amplification as for dsDD. Amplicons were incubated 1 h at room temperature with streptavidin magnasphere paramagnetic (Promega, Madison, WI, USA) in 500 l SSC 0.5×, washed twice with SSC 0.1× and denatured with 100 l of NaOH 0.2 M 5 min. The eluted non-biotinylated ssDNA was then precipitated in isopropanol. The quality of ssDD was analyzed by agarose gel electrophoresis and quantities measured by spectrophotometer.
GOREC molecules
GOREC molecules were obtained either by mixing the TFO guides (covalently linked to adapter) with the ssDD by heating 1 min at 100°C and then returning to room temperature in 6 h in order to hybridize the adapter to the 5' end of the ssDD, or using the adapter as a primer (instead of the primer 1360) for PCR amplification to obtain a covalently linked dsDD with TFO guides.
Cell culture and transfection CHO cells were derived from CHO-K1 cells (ATCC, Rockville, MD, USA) and were generous gifts from Dr B Lopez (CEA, Fontenay-aux-Roses, France). Cells were grown in Dulbecco's modified Eagle's medium (Gibco BRL) supplemented with 10% fetal bovine serum, 100 U/ml streptomycin, 100 U/ml penicillin and 2 mM glutamine.
For transfection experiments, 2 × 10 5 cells were seeded per well in a 24-well plate 24 h before transfection. About 1.2 g of DNA (plasmids, donor DNA and/or GOREC molecule) was incubated 20 min at room temperature with 2 g of polyethyleneimine (PEI Exgen 500; Euromedex, Souffelweyersheim, France) in a final volume of 20 l NaCl 0.9%. After 2 h incubation at 37°C, the cells were washed and 1 ml of fresh medium added.
Gene correction efficiency
To evaluate the efficiency of gene correction, 48 h after transfection, cells were observed by epifluorescence microscopy (DM-IL, Leica Microsystems) and were counted by fluorescence-activated cell sorting device (FACS, Becton-Dickinson). The efficiency of extrachromosomal gene correction was assessed by the ratio of the number of fluorescent cells obtained 48 h after transfection with pEGFPstopTPX in the presence of GOREC molecules to the number of fluorescent cells obtained with pEGFP-TPX under the same condition. Assays were performed in triplicates.
